ERYDEL
Based in Urbino, EryDel has developed and patented a technology for drug delivery of pharmacological agents through erythrocytes (red blood cells). This process allow to easily load red blood cells with drugs, proteins, contrasting agents for diagnostic purposes, nanoparticles etc. that can be progressively released into the patient body thus allowing an increased efficacy of the therapy and a reduction of collateral effects. The benefit is extremely significant particularly for chronic pathol... ogies that requires continuous daily treatments for patients which could be substituted by monthly transfusion of blood loaded with specific therapeutic agents. Currently, the solution has been tested by several patients for the treatment of Inflammatory Bowel Diseases (IBDs) such as ulcer colitis and Crohn disease. The company can provide a complete support for the drug delivery process including a specific device for the erythrocytes loading ("Red Cell Loader"), and disposable kits.
ERYDEL
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2007-02-01
Address:
San Giovanni, Molise, Italy
Country:
Italy
Website Url:
http://www.erydel.com
Total Employee:
11+
Status:
Active
Contact:
+39 02 36504470
Email Addresses:
[email protected]
Total Funding:
29 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Content Delivery Network Apache Microsoft Exchange Online Office 365 Mail
Similar Organizations
1200 Pharma
1200 Pharma is a medicinal chemistry technology company that accelerates pre-clinical drug discovery and clinical approval timelines.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
FORMA Therapeutics
FORMA Therapeutics is a biopharmaceutical company focused on the discovery, development, and commercialization of transformative medicines.
Kytopen
Kytopen developer of a cell therapy platform for non-viral delivery of molecules into hard-to-transfect immune cells.
Radius Health
Radius Health develops drug therapies for osteoporosis and women’s health.
Current Employees Featured
Founder
Investors List
Innogest Capital
Innogest Capital investment in Series B - Erydel
Genextra
Genextra investment in Series B - Erydel
Sofinnova Partners
Sofinnova Partners investment in Series B - Erydel
Innogest Capital
Innogest Capital investment in Series A - Erydel
FM Management
FM Management investment in Series A - Erydel
Official Site Inspections
http://www.erydel.com Semrush global rank: 6.69 M Semrush visits lastest month: 874
- Host name: 242.50.233.35.bc.googleusercontent.com
- IP address: 35.233.50.242
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
